Literature DB >> 36228250

Mutagenic damage among bronchiectasis patients attending in the pulmonology sector of a hospital in southern Brazil.

Daniel Wenceslau Votto Olmedo1,2, Katheryne Benini Martins1,2, Milene Machado Paz1,2, Caroline Lopes Feijo Fernandes1,3, Flavio Manoel Rodrigues da Silva Júnior1,3, Daniela Fernandes Ramos1,2.   

Abstract

OBJECTIVE: Bronchiectasis is a chronic respiratory disease characterized by inflammation, irreversible dilation of the bronchi, and recurrent pulmonary infections, with a high morbidity and mortality rate, but is less studied from the point of view of its prevalence and associated factors not directly related to respiratory prognosis. As it is a disease related to the exacerbation of the inflammatory process and oxidative stress, this study searched to investigate the micronucleus frequency in patients with and without bronchiectasis treated at a specialized pulmonology service in a hospital in the extreme south of Brazil.
METHODS: Patients with a confirmed tomographic diagnosis of bronchiectasis were defined as cases. Mutagenicity was evaluated by the micronucleus test in patients' oral mucosa cells. Data collection was performed through a questionnaire containing socioeconomic, demographic, lifestyle, and health condition information.
RESULTS: Of the 95 patients involved in this study, 21 (22.1%) were diagnosed with bronchiectasis aged between 12 and 89 years. There was no significant difference in the frequency of micronucleus between patients with and without bronchiectasis. There was a significant positive association between age and frequency of micronucleus among patients with bronchiectasis, but this association does not occur among patients without the disease.
CONCLUSION: This is the first study to investigate data on the prevalence and clinical and epidemiological aspects of this chronic disease in Brazil, especially those related to the genotoxicity outcome.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36228250      PMCID: PMC9575028          DOI: 10.1590/1806-9282.20220178

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.712


  28 in total

1.  Bronchiectasis in Germany: a population-based estimation of disease prevalence.

Authors:  Felix C Ringshausen; Andrés de Roux; Roland Diel; David Hohmann; Tobias Welte; Jessica Rademacher
Journal:  Eur Respir J       Date:  2015-08-20       Impact factor: 16.671

Review 2.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

3.  DNA damage in peripheral blood of patients with chronic obstructive pulmonary disease (COPD).

Authors:  Sharbel Weidner Maluf; Michelle Mergener; Luciane Dalcanale; Cassia C Costa; Tiago Pollo; Michele Kayser; Luciano Basso da Silva; Daniel Pra; Paulo José Zimermann Teixeira
Journal:  Mutat Res       Date:  2006-10-27       Impact factor: 2.433

Review 4.  The biology of pulmonary exacerbations in bronchiectasis.

Authors:  Francesco Amati; Edoardo Simonetta; Andrea Gramegna; Paolo Tarsia; Martina Contarini; Francesco Blasi; Stefano Aliberti
Journal:  Eur Respir Rev       Date:  2019-11-20

Review 5.  Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD.

Authors:  Saravanan Rajendrasozhan; Se-Ran Yang; Indika Edirisinghe; Hongwei Yao; David Adenuga; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2008-04       Impact factor: 8.401

Review 6.  Chronic obstructive pulmonary disease: molecular and cellular mechanisms.

Authors:  P J Barnes; S D Shapiro; R A Pauwels
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671

Review 7.  Non-cystic fibrosis bronchiectasis in the elderly: current perspectives.

Authors:  Tom M Quinn; Adam T Hill
Journal:  Clin Interv Aging       Date:  2018-09-10       Impact factor: 4.458

8.  Brazilian consensus on non-cystic fibrosis bronchiectasis.

Authors:  Mônica Corso Pereira; Rodrigo Abensur Athanazio; Paulo de Tarso Roth Dalcin; Mara Rúbia Fernandes de Figueiredo; Mauro Gomes; Clarice Guimarães de Freitas; Fernando Ludgren; Ilma Aparecida Paschoal; Samia Zahi Rached; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

9.  Effects of age, sex, medication, and environmental conditions on genetic alterations in oral mucosa cells.

Authors:  Deborah Navit de Carvalho Cavalcante; Bruno do Amaral Crispim; Beatriz Barufatti Grisolia; Lucilene Finoto Viana; Nayara Halimy Maran; Julio César Jut Solórzano; Kelly Mari Pires de Oliveira; Alexeia Barufatti
Journal:  Heliyon       Date:  2019-06-10

10.  Prevalence and burden of bronchiectasis in a lung cancer screening program.

Authors:  Maria Sanchez-Carpintero Abad; Pablo Sanchez-Salcedo; Juan P de-Torres; Ana B Alcaide; Luis M Seijo; Jesus Pueyo; Gorka Bastarrika; Javier J Zulueta; Arantza Campo
Journal:  PLoS One       Date:  2020-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.